Antibrush Border Antibody Disease: A Case Report and Literature Review

[1]  A. Gallan,et al.  Anti-LRP2 Nephropathy , 2020, Kidney international reports.

[2]  Xiaoye Zhu,et al.  Complete remission of nephrotic syndrome in a young woman with anti-LRP2 nephropathy after immunosuppressive therapy , 2020, BMC Nephrology.

[3]  C. Larsen,et al.  Anti–Brush Border Antibody Disease (Anti-LRP2 Nephropathy) Associated With Lupus Nephritis , 2020, Kidney international reports.

[4]  Y. Caliskan,et al.  A case of immune complex mediated tubulointerstitial disease and nephrotic syndrome: anti LRP-2 Nephropathy with diffuse podocyte effacement , 2020, Journal of Nephrology.

[5]  Philipp W. Raess,et al.  Anti-LRP2 nephropathy with concurrent kidney infiltration by lymphoma , 2019, Clinical kidney journal.

[6]  R. Kayton,et al.  Anti-LRP2 Nephropathy With Abundant IgG4-Positive Plasma Cells: A Case Report. , 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  J. Klein,et al.  LDL Receptor-Related Protein 2 (Megalin) as a Target Antigen in Human Kidney Anti-Brush Border Antibody Disease. , 2017, Journal of the American Society of Nephrology : JASN.

[8]  E. Carney.  Tubular disease: Anti-LRP2 nephropathy , 2018, Nature Reviews Nephrology.

[9]  J. Kopp,et al.  Focal Segmental Glomerulosclerosis. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[10]  R. Colvin,et al.  Immune Complex Tubulointerstitial Nephritis Due to Autoantibodies to the Proximal Tubule Brush Border. , 2016, Journal of the American Society of Nephrology : JASN.

[11]  L. Barisoni.  Diagnostic Pathology: Kidney Diseases , 2015 .

[12]  F. Machado Ribeiro,et al.  Mycobacteria and autoimmunity , 2015, Lupus.

[13]  Ying Chen,et al.  Silica exposure and altered regulation of autoimmunity , 2014, Environmental Health and Preventive Medicine.

[14]  L. Cornell.  IgG4-related kidney disease. , 2012, Seminars in diagnostic pathology.

[15]  Y. Shoenfeld,et al.  Infections and autoimmunity--friends or foes? , 2009, Trends in immunology.

[16]  R. Segal,et al.  Auto-antibody profiles in patients with active pulmonary tuberculosis. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  G. Cooper,et al.  Occupational exposures and risk of systemic lupus erythematosus , 2005, Autoimmunity.

[18]  R. Pieters,et al.  Immunomodulatory effects of tetrachlorobenzoquinone, a reactive metabolite of hexachlorobenzene. , 2003, Chemical research in toxicology.

[19]  S. Khuder,et al.  Environmental Risk Factors for Rheumatoid Arthritis , 2002, Reviews on environmental health.

[20]  V. D’Agati,et al.  Idiopathic hypocomplementemic interstitial nephritis with extensive tubulointerstitial deposits. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  J. Tekstra,et al.  Autoimmune effects of hexachlorobenzene in the rat. , 1993, Toxicology and applied pharmacology.

[22]  V. D’Agati,et al.  Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis. , 1986, Nephron.

[23]  T. Skogh,et al.  Anti-brush border antibodies (ABBA) in Crohn's disease. , 1982, Journal of clinical & laboratory immunology.

[24]  E. Lewis,et al.  Evidence of autologous immune-complex nephritis. , 1981, The New England journal of medicine.

[25]  J. Mcphaul,et al.  Primary tubulointerstitial nephritis caused by antibodies to proximal tubular antigens. , 1981, American journal of clinical pathology.